Ras mutations are implicated in a variety of cancers. For instance, KRAS mutations are prevalent in pancreatic, colorectal, and lung cancers. NRAS mutations are commonly found in melanoma and hematologic malignancies, while HRAS mutations are associated with bladder cancer and certain head and neck cancers. Understanding the specific type of Ras mutation can help in the diagnosis and treatment of these cancers.